Carlos Kuria, MD | |
550 University Blvd Rm 641, Indianapolis, IN 46202-5149 | |
(317) 944-1816 | |
(317) 948-2803 |
Full Name | Carlos Kuria |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 550 University Blvd Rm 641, Indianapolis, Indiana |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992334312 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 01087635A (Indiana) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Entity Name | Signify Health Medical Associates Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20190903001552 |
News Archive
Fusion plasma researchers at the University of Warwick have teamed up with Cambridge neuroscientists to apply their expertise developed to study inaccessible fusion plasmas in order to significantly improve the understanding of the data obtained from non-invasive study of the fast dynamics of networks in the human brain.
An automated "sample-to-answer" system could provide Ebola virus disease (EVD) diagnosis more quickly and easily than the current standard test, according to research published this week in PLOS Medicine.
Two Johns Hopkins University computer scientists have found a way to use Twitter to track public health trends, according to a Johns Hopkins University press release.
Researchers at MIND Institute at UC Davis and Rush University Medical Center have found that mavoglurant, an experimental drug known as a mGluR5 negative modulator, can positively modify a key characteristic behavior in individuals with fragile X syndrome.
Researchers from UC San Francisco and the Chan Zuckerberg Biohub have developed a new approach for COVID-19 testing that detects a distinct pattern of immune gene expression in infected individuals.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Carlos Kuria, MD 550 University Blvd Rm 641, Indianapolis, IN 46202-5149 Ph: (317) 944-1816 | Carlos Kuria, MD 550 University Blvd Rm 641, Indianapolis, IN 46202-5149 Ph: (317) 944-1816 |
News Archive
Fusion plasma researchers at the University of Warwick have teamed up with Cambridge neuroscientists to apply their expertise developed to study inaccessible fusion plasmas in order to significantly improve the understanding of the data obtained from non-invasive study of the fast dynamics of networks in the human brain.
An automated "sample-to-answer" system could provide Ebola virus disease (EVD) diagnosis more quickly and easily than the current standard test, according to research published this week in PLOS Medicine.
Two Johns Hopkins University computer scientists have found a way to use Twitter to track public health trends, according to a Johns Hopkins University press release.
Researchers at MIND Institute at UC Davis and Rush University Medical Center have found that mavoglurant, an experimental drug known as a mGluR5 negative modulator, can positively modify a key characteristic behavior in individuals with fragile X syndrome.
Researchers from UC San Francisco and the Chan Zuckerberg Biohub have developed a new approach for COVID-19 testing that detects a distinct pattern of immune gene expression in infected individuals.
› Verified 7 days ago